Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank60
3Y CAGR-5.4%
5Y CAGR+21.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-5.4%/yr
Annual compound
5Y CAGR
+21.4%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $71.64M | -17.6% |
| 2023 | $86.89M | +127.2% |
| 2022 | $38.25M | -54.8% |
| 2021 | $84.70M | +327.0% |
| 2020 | $19.84M | -27.0% |
| 2019 | $27.16M | - |